. . . . . . . "[The MDM2 inhibitor, RG7388, was examined alone or in combination with XRT (20Gy given in 2?Gy daily fractions) to immune-deficient mice bearing Rh18 (embryonal) or a total of 30?Gy in 2?Gy fractions to mice bearing Rh30 (alveolar) rhabdomyosarcoma xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:14:28+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .